Ultrasonography
DeviceComparison of B-mode US alone and combined use of elasto-doppler US along with B-mode US.
Other names: Aixplorer system (SuperSonic Imagine, France), EUB-series/HV-ASCENDUS (Hitachi Medical, Japan)
NCT Number: NCT01963624
The investigators hypothesis is that the combined use of elastography and color doppler ultrasonography can increase positive-predictive value of breast screening with ultrasound.
Looking for future studies?
Notify Me30 year and older
Female
Observational
Dongnam Inst. of Radiological and Medical Sciences, Busan, South Korea
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Comparison of B-mode US alone and combined use of elasto-doppler US along with B-mode US.
Other names: Aixplorer system (SuperSonic Imagine, France), EUB-series/HV-ASCENDUS (Hitachi Medical, Japan)
Time frame: 1 year after enrollment
Stability for 1 year of follow-up is needed for the confirmation of benign lesions if they do not undergo biopsy.
Time frame: 1 year after enrollment
Stability for 1 year of follow-up is needed for the confirmation of benign lesions if they do not undergo biopsy.
Time frame: 1 year after enrollment
Stability for 1 year of follow-up is needed for the confirmation of benign lesions if they do not undergo biopsy.
Time frame: 1 year after enrollment
Stability for 1 year of follow-up is needed for the confirmation of benign lesions if they do not undergo biopsy.
Seoul National University Hospital
Other
Multicenter Prospective Study to Evaluate the Value of Combined Elastography and Color Doppler Ultrasonography for Breast Screening With Ultrasound
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT05754658
Breast Cancer, Breast Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07040514
Breast Cancer, Breast Diseases
Lebanon, New Hampshire, United States
View Trial DetailsNCT06604858
Breast Cancer, Breast Diseases
A Coruña, Spain
View Trial Details